SocialDiabetes, SL

SocialDiabetes is a digital healthcare company focused on improving diabetes management through an innovative platform that combines medical tools and applications for better patient care. Founded in 2011 in Barcelona, Spain, SocialDiabetes specializes in diabetes management solutions. The company was established by María Rojo and Víctor Bermúdez. María Rojo, who also serves as CEO, has a history of founding health-tech initiatives.

SocialDiabetes raised EUR 1. 60 mn in Grant funding from the European Commission in its latest round, bringing its total amount raised to EUR 0. 15 mn. The company has completed four funding deals, with the most recent deal occurring on April 19, 2018.

SocialDiabetes provides a comprehensive digital platform designed for diabetes management, featuring an application and medical tools to enhance care quality for individuals with diabetes. The platform facilitates automatic data collection, enabling real-time monitoring of glucose levels, medication adherence, and dietary management, thereby aiding both patients and healthcare professionals in making informed decisions. Its primary customer base includes diabetes patients, healthcare providers, and diabetes-focused organizations. The company's products are accessible in various international markets.

In 2023, SocialDiabetes reported a revenue of EUR 595,746. 30 with an EBITDA of EUR -122,898. 30, reflecting the financial performance of its subscription-based services which offer advanced analytics and personalized feedback to users for improved diabetes management. SocialDiabetes plans to launch new product features aimed at enhancing the user experience in diabetes management.

The company is also targeting expansion into additional international markets by 2025. The recent funding will support these initiatives, allowing for the development of new functionalities and a broader outreach to users, ultimately facilitating better healthcare engagement.